Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Asset Utilization Ratio (2019 - 2025)

UroGen Pharma's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.57 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 85.14% year-over-year to 0.57; the TTM value through Dec 2025 reached 0.57, up 85.14%, while the annual FY2025 figure was 0.45, 15.92% up from the prior year.
  • Asset Utilization Ratio reached 0.57 in Q4 2025 per URGN's latest filing, up from 0.49 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.7 in Q2 2023 to a low of 0.18 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.41, with a median of 0.4 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: surged 180222.4% in 2021, then crashed 49.38% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.38 in 2021, then grew by 29.02% to 0.49 in 2022, then decreased by 8.75% to 0.44 in 2023, then tumbled by 30.83% to 0.31 in 2024, then skyrocketed by 85.14% to 0.57 in 2025.
  • Per Business Quant, the three most recent readings for URGN's Asset Utilization Ratio are 0.57 (Q4 2025), 0.49 (Q3 2025), and 0.41 (Q2 2025).